Sumitomo Pharma Snapshot
Healthy bodies, healthy lives," is the goal of Dainippon Sumitomo Pharma (DSP). Through research and development, the Japanese drugmaker produces a wide range of therapeutics in such categories as cardiovascular disease, gastrointestinal disorders, and infections. These include blood pressure medication Amlodin, digestive tract treatment Gasmotin, and antibiotic Meropen. Subsidiary Sunovion develops and markets central nervous system and respiratory drugs in North America; its top-selling product is insomnia therapy Lunesta. DSP also makes food and feed additives, veterinary drugs, fine chemicals, and diagnostic reagents used in research and clinical laboratories. Sumitomo Chemical owns just over half of DSP
